3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
44
Breast Neoplasms
42
Lung Neoplasms
27
Carcinoma, Non-Small-Cell Lung
21
Colorectal Neoplasms
19
Prostatic Neoplasms
14
Uterine Cervical Neoplasms
13
Ovarian Neoplasms
11
Head and Neck Neoplasms
11
Pancreatic Neoplasms
10
Melanoma
10
Carcinoma, Hepatocellular
10
Brain Neoplasms
9
Sarcoma
7
Neoplastic Cells, Circulating
7
Myelodysplastic Syndromes
7
Glioma
7
Multiple Myeloma
6
Gastrointestinal Neoplasms
6
Esophageal Neoplasms
6
Endometrial Neoplasms
6
Disease
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Leukemia, Myeloid, Acute
5
Colonic Neoplasms
5
Uveal Melanoma
4
Skin Neoplasms
4
Neoplasm, Residual
4
Interventions
Carboplatin
5
pembrolizumab
3
Paclitaxel
3
Observation
3
Capecitabine
3
Azacitidine
3
venetoclax
2
pertuzumab
2
olaparib
2
durvalumab
2
Tretinoin
2
Trastuzumab
2
Standard of Care
2
Oxaliplatin
2
Irinotecan
2
Immunotherapy
2
Chemoradiotherapy
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
toripalimab
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
taxane
1
talazoparib
1
tagraxofusp
1
sarilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Blood Specimen Collection
×
1 year
×
Clear all
No trials found.